<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
    <title>The MedTech Meeting</title>
    <description>
      <![CDATA[]]>
    </description>
    <link>https://www.bioworld.com/rss</link>
    <language>en-us</language>
    <item>
      <title>Advamed hopeful House breakthrough device bill will pass in ‘24</title>
      <description>
        <![CDATA[The med-tech industry has been keen to see government fill in the so-called valley of death for breakthrough medical devices for some years, and 2024 may be the year it is finally done. Scott Whitaker, president and CEO of the Advanced Medical Technology Association said in an Oct. 16 press briefing that a House bill may pass during the upcoming lame duck session, bringing to a close an effort that has been the better part of a decade in the making.]]>
      </description>
      <guid>http://www.bioworld.com/articles/713166</guid>
      <pubDate>Thu, 17 Oct 2024 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/713166-advamed-hopeful-house-breakthrough-device-bill-will-pass-in-24</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Geographic-regions/US/regulatory-washington-capital.webp?t=1588689711" type="image/png" medium="image" fileSize="560021">
        <media:title type="plain">U.S. Capitol building, Washington D.C.</media:title>
      </media:content>
    </item>
    <item>
      <title>CBO scoring impedes expanded Medicare digital benefit categories</title>
      <description>
        <![CDATA[The U.S. Medicare program has a notorious problem with regard to coverage of digital products and software as a service, but the agency is dependent on Congress to add new benefit categories via legislation.]]>
      </description>
      <guid>http://www.bioworld.com/articles/713155</guid>
      <pubDate>Wed, 16 Oct 2024 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/713155-cbo-scoring-impedes-expanded-medicare-digital-benefit-categories</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/AI/AI-biotech-research-concept.webp?t=1721078093" type="image/jpeg" medium="image" fileSize="330267">
        <media:title type="plain">AI biotech research concept with lightbulb and digital background</media:title>
      </media:content>
    </item>
    <item>
      <title>US Judicial Conference eyes third-party litigation funding</title>
      <description>
        <![CDATA[Third-party litigation funding has been a source of controversy in the U.S. over the past decade, but the practice drew little national scrutiny up to now.]]>
      </description>
      <guid>http://www.bioworld.com/articles/713144</guid>
      <pubDate>Tue, 15 Oct 2024 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/713144-us-judicial-conference-eyes-third-party-litigation-funding</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Regulatory/Gavel-and-vials.webp?t=1661548987" type="image/png" medium="image" fileSize="778402">
        <media:title type="plain">Gavel and vials</media:title>
      </media:content>
    </item>
    <item>
      <title>Report puts emphasis on partnering to thrive in the new era of med tech</title>
      <description>
        <![CDATA[]]>
      </description>
      <guid>http://www.bioworld.com/articles/430215</guid>
      <pubDate>Fri, 27 Sep 2019 00:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/430215-report-puts-emphasis-on-partnering-to-thrive-in-the-new-era-of-med-tech</link>
    </item>
    <item>
      <title>Shuren cites need for flexibility, says regulatory Legos the prescription</title>
      <description>
        <![CDATA[BOSTON – The 2019 Medtech Conference included the annual FDA town hall session, and Jeff Shuren, director of the agency's device center, said the pace of scientific change is outstripping the agency's ability to keep up. Shuren said the solution might be "regulatory Legos," an approach that might eliminate the need to go to Congress for new statutory authorities every time device makers carve open a new technological frontier.]]>
      </description>
      <guid>http://www.bioworld.com/articles/430213</guid>
      <pubDate>Fri, 27 Sep 2019 00:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/430213-shuren-cites-need-for-flexibility-says-regulatory-legos-the-prescription</link>
    </item>
    <item>
      <title>Panel digs down on digital transformation in med tech</title>
      <description>
        <![CDATA[]]>
      </description>
      <guid>http://www.bioworld.com/articles/430216</guid>
      <pubDate>Fri, 27 Sep 2019 00:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/430216-panel-digs-down-on-digital-transformation-in-med-tech</link>
    </item>
    <item>
      <title>Panel focuses on taking the med-tech industry's pulse and looking to the future</title>
      <description>
        <![CDATA[BOSTON – How are med-tech companies reacting to the findings of the EY Pulse of the Industry report 2019? Members of a panel examined this question this week during the Medtech Conference in Boston, while also offering their insight on where the industry is headed.]]>
      </description>
      <guid>http://www.bioworld.com/articles/430123</guid>
      <pubDate>Thu, 26 Sep 2019 00:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/430123-panel-focuses-on-taking-the-med-tech-industrys-pulse-and-looking-to-the-future</link>
    </item>
    <item>
      <title>Panel casts light on how data can transform health care, challenges companies face</title>
      <description>
        <![CDATA[]]>
      </description>
      <guid>http://www.bioworld.com/articles/430115</guid>
      <pubDate>Thu, 26 Sep 2019 00:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/430115-panel-casts-light-on-how-data-can-transform-health-care-challenges-companies-face</link>
    </item>
    <item>
      <title>IP enforcement in China improving slowly but surely</title>
      <description>
        <![CDATA[]]>
      </description>
      <guid>http://www.bioworld.com/articles/430479</guid>
      <pubDate>Wed, 25 Sep 2019 00:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/430479-ip-enforcement-in-china-improving-slowly-but-surely</link>
    </item>
    <item>
      <title>Companies' focus on outcomes transforming med-tech innovation</title>
      <description>
        <![CDATA[BOSTON – The shift to value-based care models and rise in digital technologies is causing medical device companies to rethink how and where they invest in innovation. There's less emphasis on core and adjacent product investments and more focus on transformational advances that don't just add new bells and whistles but expand access, improve outcomes and lower costs. Just what that looks like and how companies are adapting to this new innovation landscape was the focus of a session at the Medtech Conference this week.]]>
      </description>
      <guid>http://www.bioworld.com/articles/430481</guid>
      <pubDate>Wed, 25 Sep 2019 00:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/430481-companies-focus-on-outcomes-transforming-med-tech-innovation</link>
    </item>
    <item>
      <title>Panelists discuss what drives success in med-tech M&amp;A, deals</title>
      <description>
        <![CDATA[BOSTON – What are companies doing to be successful in the current environment of med-tech M&A valuation? That question was posed to panelists from three top device makers during the Medtech Conference Tuesday morning. Specifically, the panel, which featured representatives from New Brunswick, N.J.-based Johnson & Johnson, Medtronic plc and Boston Scientific Corp., looked at overall valuations across the sector, as well as what it takes to produce a successful M&A strategy.]]>
      </description>
      <guid>http://www.bioworld.com/articles/430478</guid>
      <pubDate>Wed, 25 Sep 2019 00:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/430478-panelists-discuss-what-drives-success-in-med-tech-ma-deals</link>
    </item>
    <item>
      <title>Advamed highlights diversity, inclusion to open annual conference</title>
      <description>
        <![CDATA[BOSTON – The Advanced Medical Technology Association (Advamed) opened its annual conference here in the capital of the Bay State with an emphasis on several policy points, including greater diversity and inclusion in the med-tech industry. Advamed board chairman Kevin Lobo said the device industry lags behind other industries in this regard, adding that device makers need to recognize that workforce diversity is "the key to innovation, the key to business success."]]>
      </description>
      <guid>http://www.bioworld.com/articles/430505</guid>
      <pubDate>Tue, 24 Sep 2019 00:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/430505-advamed-highlights-diversity-inclusion-to-open-annual-conference</link>
    </item>
    <item>
      <title>FDA lays framework for engaging patients in device clinical trials</title>
      <description>
        <![CDATA[BOSTON – The FDA's Center for Device and Radiological Health (CDRH) released draft guidance on Monday aimed at encouraging the use of patient input in medical device clinical trials and helping sponsors understand how they can use patient engagement to improve the design and conduct of investigations.]]>
      </description>
      <guid>http://www.bioworld.com/articles/430506</guid>
      <pubDate>Tue, 24 Sep 2019 00:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/430506-fda-lays-framework-for-engaging-patients-in-device-clinical-trials</link>
    </item>
    <item>
      <title>Panel looks at strategies to address the challenges and opportunities of the new 'longevity economy'</title>
      <description>
        <![CDATA[BOSTON – How are some of the newer technologies and players being harnessed to address the needs of aging populations? That question kicked off a session titled "Revolutionizing the Silver Economy," which took place at the Medtech Conference in Boston on Monday.]]>
      </description>
      <guid>http://www.bioworld.com/articles/430504</guid>
      <pubDate>Tue, 24 Sep 2019 00:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/430504-panel-looks-at-strategies-to-address-the-challenges-and-opportunities-of-the-new-longevity-economy</link>
    </item>
  </channel>
</rss>
